Oncology Institute, Inc. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Oncology Institute, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • Oncology Institute, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$16.4M, a 9.55% decline year-over-year.
  • Oncology Institute, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$63.5M, a 31.7% increase year-over-year.
  • Oncology Institute, Inc. annual Operating Income (Loss) for 2023 was -$77M, a 6.02% increase from 2022.
  • Oncology Institute, Inc. annual Operating Income (Loss) for 2022 was -$82M, a 78.7% decline from 2021.
  • Oncology Institute, Inc. annual Operating Income (Loss) for 2021 was -$45.9M, a 459% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$77M +$4.93M +6.02% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$82M -$36.1M -78.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$45.9M -$37.7M -459% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$8.2M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.